歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 其他抗體 > CDKN1B抗原(重組蛋白)

產(chǎn)品中心

  • CDKN1B抗原(重組蛋白)

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW9993
    • 應(yīng)用 : 0
    • 保存條件 : 0
    • 貨期 : 0
    • 商品庫存:100
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品

中文名稱:CDKN1B抗原(重組蛋白)

英文名稱:
CDKN1B Antigen (Recombinant Protein)

儲      存:
冷凍(-20℃)

相關(guān)類別:抗原

概述

Fusion protein corresponding to a region derived from 1-198 amino acids of human CDKN1B


技術(shù)規(guī)格

Full name:

cyclin dependent kinase inhibitor 1B

Synonyms:

KIP1; MEN4; CDKN4; MEN1B; P27KIP1

Swissprot:

P46527

Gene Accession:

BC001971

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).